1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PLacquired partial lipodystrophy, partial lipodystrophyActive, not recruitingPhase 32026-06-15NCT05164341